These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 15331428

  • 1. Inhibition of cholesteryl ester transfer protein activity by JTT-705 increases apolipoprotein E-containing high-density lipoprotein and favorably affects the function and enzyme composition of high-density lipoprotein in rabbits.
    Zhang B, Fan P, Shimoji E, Xu H, Takeuchi K, Bian C, Saku K.
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1910-5. PubMed ID: 15331428
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of cholesteryl ester transfer protein increases serum apolipoprotein (apo) A-I levels by increasing the synthesis of apo A-I in rabbits.
    Shimoji E, Zhang B, Fan P, Saku K.
    Atherosclerosis; 2004 Feb; 172(2):247-57. PubMed ID: 15019534
    [Abstract] [Full Text] [Related]

  • 3. A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits.
    Okamoto H, Yonemori F, Wakitani K, Minowa T, Maeda K, Shinkai H.
    Nature; 2000 Jul 13; 406(6792):203-7. PubMed ID: 10910363
    [Abstract] [Full Text] [Related]

  • 4. Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib.
    Clark RW, Sutfin TA, Ruggeri RB, Willauer AT, Sugarman ED, Magnus-Aryitey G, Cosgrove PG, Sand TM, Wester RT, Williams JA, Perlman ME, Bamberger MJ.
    Arterioscler Thromb Vasc Biol; 2004 Mar 13; 24(3):490-7. PubMed ID: 14739125
    [Abstract] [Full Text] [Related]

  • 5. Raising high-density lipoprotein with cholesteryl ester transfer protein inhibitors.
    Clark RW.
    Curr Opin Pharmacol; 2006 Apr 13; 6(2):162-8. PubMed ID: 16487747
    [Abstract] [Full Text] [Related]

  • 6. Effect of inhibiting cholesteryl ester transfer protein on the kinetics of high-density lipoprotein cholesteryl ester transport in plasma: in vivo studies in rabbits.
    Kee P, Caiazza D, Rye KA, Barrett PH, Morehouse LA, Barter PJ.
    Arterioscler Thromb Vasc Biol; 2006 Apr 13; 26(4):884-90. PubMed ID: 16373610
    [Abstract] [Full Text] [Related]

  • 7. Decrease of hepatic triglyceride lipase levels and increase of cholesteryl ester transfer protein levels in patients with primary biliary cirrhosis: relationship to abnormalities in high-density lipoprotein.
    Hiraoka H, Yamashita S, Matsuzawa Y, Kubo M, Nozaki S, Sakai N, Hirano K, Kawata S, Tarui S.
    Hepatology; 1993 Jul 13; 18(1):103-10. PubMed ID: 8325601
    [Abstract] [Full Text] [Related]

  • 8. Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease.
    Barter PJ, Kastelein JJ.
    J Am Coll Cardiol; 2006 Feb 07; 47(3):492-9. PubMed ID: 16458126
    [Abstract] [Full Text] [Related]

  • 9. Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice.
    Berti JA, Amaral ME, Boschero AC, Nunes VS, Harada LM, Castilho LN, Oliveira HC.
    Metabolism; 2001 May 07; 50(5):530-6. PubMed ID: 11319713
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of inhibition of cholesteryl ester transfer protein by JTT-705 in combination with pravastatin in type II dyslipidemia.
    Kuivenhoven JA, de Grooth GJ, Kawamura H, Klerkx AH, Wilhelm F, Trip MD, Kastelein JJ.
    Am J Cardiol; 2005 May 01; 95(9):1085-8. PubMed ID: 15842977
    [Abstract] [Full Text] [Related]

  • 11. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
    Westerterp M, van der Hoogt CC, de Haan W, Offerman EH, Dallinga-Thie GM, Jukema JW, Havekes LM, Rensen PC.
    Arterioscler Thromb Vasc Biol; 2006 Nov 01; 26(11):2552-9. PubMed ID: 16946130
    [Abstract] [Full Text] [Related]

  • 12. Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesis.
    Klerkx AH, El Harchaoui K, van der Steeg WA, Boekholdt SM, Stroes ES, Kastelein JJ, Kuivenhoven JA.
    Arterioscler Thromb Vasc Biol; 2006 Apr 01; 26(4):706-15. PubMed ID: 16439711
    [Abstract] [Full Text] [Related]

  • 13. Effects of testosterone replacement on HDL subfractions and apolipoprotein A-I containing lipoproteins.
    Tan KC, Shiu SW, Pang RW, Kung AW.
    Clin Endocrinol (Oxf); 1998 Feb 01; 48(2):187-94. PubMed ID: 9579231
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cholesteryl ester transfer protein promotes the formation of cholesterol-rich remnant like lipoprotein particles in human plasma.
    Okamoto H, Miyai A, Sasase T, Furukawa N, Matsushita M, Nakano T, Nakajima K.
    Clin Chim Acta; 2007 Jan 01; 375(1-2):92-8. PubMed ID: 16859664
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of hepatic HDL-related mRNAs on plasma prebeta HDL in cholesterol-fed rabbits.
    Sugano M, Makino N, Yanaga T.
    Artery; 1997 Jan 01; 22(4):182-205. PubMed ID: 9576025
    [Abstract] [Full Text] [Related]

  • 18. Elevated HDL2-paraoxonase and reduced CETP activity are associated with a dramatically lower ratio of LDL-cholesterol/total cholesterol in a hypercholesterolemic and hypertriglyceridemic patient.
    Lee JH, Park JH, Lee SH, Kim JR, Cho KH.
    Int J Mol Med; 2010 Jun 01; 25(6):945-51. PubMed ID: 20428800
    [Abstract] [Full Text] [Related]

  • 19. The functional and compositional properties of lipoproteins are altered in patients with metabolic syndrome with increased cholesteryl ester transfer protein activity.
    Park KH, Shin DG, Kim JR, Hong JH, Cho KH.
    Int J Mol Med; 2010 Jan 01; 25(1):129-36. PubMed ID: 19956911
    [Abstract] [Full Text] [Related]

  • 20. Dual effects on HDL metabolism by cholesteryl ester transfer protein inhibition in HepG2 cells.
    Huang Z, Inazu A, Kawashiri MA, Nohara A, Higashikata T, Mabuchi H.
    Am J Physiol Endocrinol Metab; 2003 Jun 01; 284(6):E1210-9. PubMed ID: 12604506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.